drugset / Trial / NCT04421911

A Study to Assess Efficacy and Safety of the Ketoprofen vs Diclofenac

NCT04421911

Phase 3 Completed 236 enrolled Handok Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

Primary objective: • To assess therapeutic efficacy of the Ketoprofen compared with Diclofenac based on the assessment of primary endpoint : Mean change in walking arthritis pain intensity score Secondary objectives: * To assess therapeutic efficacy of the Ketoprofen compared with Diclofenac based on the assessment of secondary endpoints. * To assess safety and tolerability of the Ketoprofen compared with Diclofenac based on the nature and frequency of adverse events in treatment groups

Timeline

Start
2020-03-20
Primary completion
2020-09-01
Completion
2020-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified Topical
Subject Ketoprofen Small molecule Topical

Indications